C12N 2501/052
Lipopolysaccharides [lps]
Official title: Lipopolysaccharides [LPS]
C12N2501/052 (Lipopolysaccharides [lps]) appears on 61 US grants and 135 published applications in this corpus.
Search patents in C12N- Granted patents
- 61
- Published applications
- 135
- Assignees
- 111
- Inventors
- 310
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 0 | 4 |
| 2007 | 1 | 5 |
| 2008 | 1 | 2 |
| 2009 | 3 | 1 |
| 2010 | 2 | 5 |
| 2011 | 4 | 5 |
| 2012 | 5 | 4 |
| 2013 | 1 | 6 |
| 2014 | 4 | 3 |
| 2015 | 0 | 8 |
| 2016 | 8 | 9 |
| 2017 | 1 | 6 |
| 2018 | 5 | 2 |
| 2019 | 2 | 8 |
| 2020 | 3 | 14 |
| 2021 | 3 | 9 |
| 2022 | 3 | 6 |
| 2023 | 6 | 6 |
| 2024 | 3 | 15 |
| 2025 | 1 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof25 Aug 2026US 12,716,055 B2Fibrobiologics, Inc.
- Method for increasing dendritic cell migration ability, and use thereof14 Apr 2026US 12,600,946 B2Cha University Industry-Academic Cooperation Foundation
- Bone marrow microglia progenitor cells and uses thereof7 Apr 2026US 12,594,305 B2Strominnate Therapeutics AB
- Culture medium and method for inducing iPSC differentiation to obtain macrophages and use thereof26 Aug 2025US 12,398,370 B2Allife Medicine (Beijing) Limited
- Physiology and pathophysiology of human gut: intestine-on-chip25 Jun 2024US 12,018,284 B2Emulate, Inc.
- Method of evaluating intercellular interactions in neuroinflammation30 Apr 2026US 2026/0118345 A1FUJIFILM Corporation
- Method to change the polarization of tumor associated macrophages by exposing them to a source of radiation in the presence of magnetosomes9 Apr 2026US 2026/0097075 A1Centre National De La Recherche Scientifique
- Macrophage-derived engineered vesicles for targeted delivery and treatment13 Nov 2025US 2025/0345283 A1University of Kentucky Research Foundation
- Stem cell-derived extracellular vesicles and methods of use thereof28 Aug 2025US 2025/0268943 A1Washington University
- Treatment of Disc Degeneration using B Regulatory Cells10 Jul 2025US 2025/0222031 A1Creative Medical Technologies, Inc.
Most cited
By later US patents
- Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications38US 6,165,785 AShriners Hospitals for Children · 2000
- Method of inducing memory B cell development and terminal differentiation33US 7,378,276 B2The United States of America as represented by the Department of Health and Human Services · 2008
- Method for producing dendritic cells23US 7,247,480 B2Isis Innovation Limited · 2007
- Method of inducing memory B cell development and terminal differentiation11US 8,247,228 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2012
- Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells8US 8,236,562 B2Argos Therapeutics, Inc. · 2012